Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock price Singapore S.E.

Equities

T14

CNE100000924

Pharmaceuticals

Delayed Singapore S.E. 03:57:04 2024-02-23 am EST 5-day change 1st Jan Change
1.89 USD +3.85% Intraday chart for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited +5.59% -8.70%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Sales 2023 * 8.55B 1.19B Sales 2024 * 9.64B 1.34B Capitalization 19.4B 2.7B
Net income 2023 * 1.08B 151M Net income 2024 * 1.28B 178M EV / Sales 2023 * 2.27 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 2.01 x
P/E ratio 2023 *
20.8 x
P/E ratio 2024 *
17.6 x
Employees 4,913
Yield 2023 *
-
Yield 2024 *
-
Free-Float 31.62%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.85%
1 week+5.59%
Current month+9.88%
1 month+6.18%
3 months-6.44%
6 months-4.06%
Current year-8.70%
More quotes
1 week
1.76
Extreme 1.76
1.90
1 month
1.66
Extreme 1.66
1.90
Current year
1.66
Extreme 1.66
2.11
1 year
1.25
Extreme 1.25
2.44
3 years
0.85
Extreme 0.845
2.44
5 years
0.51
Extreme 0.505
2.44
10 years
0.51
Extreme 0.505
2.44
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 22-08-21
Chief Tech/Sci/R&D Officer 54 12-11-30
42 -
Members of the board TitleAgeSince
Director/Board Member 55 19-09-29
Director/Board Member 68 20-06-04
Chief Tech/Sci/R&D Officer 54 12-11-30
More insiders
Date Price Change Volume
24-02-23 1.89 +3.85% 29,600
24-02-22 1.82 +1.11% 165,500
24-02-21 1.8 +0.56% 127,000
24-02-20 1.79 -0.56% 253,100
24-02-19 1.8 +0.56% 74,700

Delayed Quote Singapore S.E., February 23, 2024 at 03:57 am EST

More quotes
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, formerly Tianjin Zhongxin Pharmaceutical Group Co Ltd, is a China-based company mainly engaged in the production, operation and scientific research of green traditional Chinese medicine. The Company's businesses cover the whole industry chain of traditional Chinese medicine, including the cultivation of Chinese medicinal materials, trade of Chinese medicinal materials, research and development (R&D), production and sales of Chinese patent medicines, production and sales of Chinese herbal decoction pieces, pharmaceutical commercial logistics, pharmaceutical retailing, chemical raw materials and preparations, biomedicine and many other fields. The Company's products include cardiovascular and cerebrovascular medicines, respiratory medicines, spleen and stomach medicines, cold medicines, oncology medicines, gynecological medicines, pediatric medicines and other other product groups.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
29.26 CNY
Average target price
44.28 CNY
Spread / Average Target
+51.33%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
  4. Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited - Singapore S.E.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW